| Financial Year |
March 31 2023 |
| Monetary Funds |
7,114,697,707.32 |
| Held-for-trading Financial Assets |
1,550,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
929,497,941.40 |
| Advances to Suppliers |
130,193,760.57 |
| Other Receivables |
98,468,959.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
821,230,861.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,000,000.00 |
| Other Current Assets |
432,763,240.70 |
| Total Current Assets |
11,429,835,913.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
7,943,082,144.24 |
| Under-construction Projects |
1,905,564,896.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,201,273,237.36 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
114,157,737.15 |
| Deferred Income Tax Assets |
281,770,127.91 |
| Other Non-Current Assets |
334,829,362.89 |
| Sub-Total of Non-Current Assets |
15,980,681,818.52 |
| Total Assets |
27,410,517,732.03 |
| Short-Term Loans |
2,004,518,783.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
60,864,111.98 |
| Accounts Payable |
2,669,033,407.56 |
| Accounts Received In Advance |
5,259,430.12 |
| Employee Compensation Payable |
961,526,854.10 |
| Taxes Payable |
422,256,988.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
383,917,269.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
185,705,966.52 |
| Other Current Liabilities |
96,247,609.10 |
| Sub-Total of Current Liabilities |
7,263,128,634.67 |
| Long-term Loans |
1,563,000,000.00 |
| Bonds Payable |
1,763,166,719.03 |
| Long-Term Accounts Payable |
793,868,736.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
969,261,064.08 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
1,108,934.91 |
| Sub-Total of Non-Current Liabilities |
5,689,461,303.41 |
| Total Liabilities |
12,952,589,938.08 |
| Paid-In Capital(Or Share Stock) |
4,611,047,544.00 |
| Capital Surplus |
2,344,246,224.09 |
| Surplus Reserve |
837,308,730.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,447,160,205.76 |
| Minority Stockholder's Interest |
432,670,595.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,025,257,198.16 |
| Owner's Equity（Stockholder's Equity） |
14,457,927,793.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
27,410,517,732.03 |
